Objective: Emergency department (ED) patients with psychiatric chief complaints undergo medical screening to rule out underlying or comorbid medical illnesses prior to transfer to a psychiatric facility. This systematic review attempts to determine the clinical utility of protocolized laboratory screening for the streamlined medical clearance of ED psychiatric patients by determining the clinical significance of individual laboratory results.
previous psychiatric diagnosis, and physician examination to guide testing." Despite this recommendation, the National Ambulatory Medical Care Survey (NAMCS) from 2010 to 2014 indicated that medical clearance tests were ordered in 80.4% of ED visits ending with a psychiatric admission. This suggests that in the United States, four out of five EDs are ordering medical clearance tests for psychiatric patients. 4 The justification for medical clearance stems from the high prevalence (24%-63%) of medical comorbidities found in psychiatric patients. [5] [6] [7] [8] The most common nonpsychiatric acute medical illnesses associated with psychiatric patients include hypertension, 9 drug intoxication, and diabetes mellitus. 10, 11 Acute medical illnesses may also cause or exacerbate psychiatric symptoms. 12 In addition, patients may have a number of undiagnosed medical illnesses, 13 which could put the patient at risk if transferred to a psychiatric facility. 14 Medical clearance of ED psychiatric patients has been a subject of controversy largely due to a lack of standardized protocols and universal agreement on the meaning of adequate screening. 2, 9, 14 Many institutions have varying routine screening procedures to exclude underlying and comorbid medical illnesses before transfer to a psychiatric facility. 6, 15 Despite this lack of consensus concerning routine medical screening, medical clearance often continues to be mandatory in the ED. 3 Typically, adequate medical clearance is believed to include at least a history and physical examination including vital signs. 6 To date, it remains unclear whether protocolized ancillary testing including laboratory screening is useful and/or beneficial prior to transfer to a psychiatric facility 3, 16 Proponents of laboratory screening contend that a history and physical examination alone are not sufficient to evaluate psychiatric patients. 16 This may be due, in part, to the thinking that symptoms reported by psychiatric patients may be less reliable. 17 Additionally, psychiatrists make logical arguments in favor of laboratory screening for patients due to emergency providers' inherent cognitive biases for this population. 18, 19 Counterarguments state that ancillary testing is associated with excess expense. Parmar et al. 16 estimates that there is an average of $197 charge per patient for mandated laboratory screening tests for pediatric patients. Additionally, Donofrio et al. 20 found that the median charge for blood and urine tests together as $1,235 for pediatric routine medical clearance laboratory tests. They suggest that eliminating protocolized laboratory testing could save $90 million annually.
In addition to excess expense, unnecessary testing is also associated with other ED psychiatric patient risks such as overcrowding and increasing ED length of stay, as well as the possibility of false-positive laboratory test results, which could lead to additional unnecessary testing and cause harm to the patient. 16 A significant decrease in psychiatric inpatient capacity in the United States has contributed to ED overcrowding and increased the burden of boarding patients awaiting transfer.
Nicks and Manthey 6 found that the ED length of stay for psychiatric patients awaiting inpatient psychiatric placement is 3.2 times longer than nonpsychiatric patients. Weiss et al. 13 indicated that the average ED length of stay for all psychiatric patients is 11.5 hours. Overcrowding in the ED is associated with substantial risks such as delays in patient care and morbidity/ mortality. In addition, prolonged ED lengths of stay have also been specifically associated with psychiatric patient safety risks including symptom exacerbation and elopement. 6 Preventing unnecessary laboratory testing is consistent with the 2015 21 and 2016 22 Academic Emergency Medicine Consensus Conferences regarding "Choosing Wisely" and "Shared Decision Making." Similar to the controversy surrounding excess ancillary testing for medical clearance of ED psychiatric patients, other forms of testing for general ED patients have been described as overused and unnecessary, such as imaging. The Choosing Wisely campaign 23 was initiated by the American Board of Internal Medicine and describes scenarios in which the prescription of imaging can be optimized to prevent unnecessary testing. 22 To date, no such consensus has been established for mandatory laboratory screening for the medical clearance of ED psychiatric patients.
Additionally, the shared decision making 22 consensus conference promotes the concept of "patient-centered health care," in which providers shift their focus from the disease and back to the individual patient and their family. Shared decision making involves optimizing treatment by having the patient and their family collaboratively participate in treatment decision making. This individualized approach toward treatment decisions relates to the counterarguments regarding mandated protocols for laboratory screening. Psychiatric patients are currently often mandated to receive a laboratory screening protocol in the ED, which fails to consider individual needs of the patient. This is particularly salient when considering the potential risks 14, 17 involved with The American Association for Emergency Psychiatry Task Force on Medical Clearance recommendations for laboratory testing are controversial and this systematic review could be a step toward harmonizing evidence with recommendations between specialties. 24 To do so, our systematic review seeks to elucidate the clinical utility of protocolized laboratory screening for the streamlined medical clearance of all psychiatric patients in the ED. Clinical utility is defined as change in disposition as a result of the laboratory tests result. We specifically seek to include general EDs that implement a medical clearance protocol (a mandated set of laboratory tests) for all psychiatric patients to eliminate the potential for selection bias associated with ordering laboratory tests according to subjective clinical judgment (nonprotocolized). General ED is defined as any ED that is not exclusive to patients with psychiatric chief complaints. Additionally, this systematic review seeks to identify subgroups of psychiatric patients who would benefit from a more targeted approach to medical clearance at baseline, such as high-risk patients (geriatric, new-onset psychiatric symptoms, preexisting or comorbid medical illnesses, and suicidal ingestion).
METHODS

Study Design
We conducted a systematic review of studies that reported results of protocolized medical clearance of general ED psychiatric patients. The review follows the recommendations of Meta-analysis of Observational Studies in Epidemiology (MOOSE) statement. 25 
Patients
We included studies that examined patients with minimum age of 16 years presenting to the ED with a psychiatric chief complaint.
Laboratory Test
We only investigated laboratory tests ordered as part of a predetermined and mandatory medical clearance protocol for all patients with psychiatric chief complaints.
Outcomes
An abnormal laboratory test result was defined as any result that falls out of the normal value range per each trials' laboratory. A clinically significant laboratory test result was defined as any abnormal result which changed patient disposition (transfer to the observation unit, transfer to the medicine floor).
Search Strategy
We conducted a systematic review of available studies on medical clearance of psychiatric patients in general EDs that implement a laboratory screening protocol. In conjunction with a medical librarian, we independently searched the medical literature up to June 2017 in PubMed, Embase, and Scopus using the search terms "emergency department, psychiatry, diagnostic tests, laboratories, studies, testing, screening, and clearance" (Data Supplement S1, available as supporting information in the online version of this paper, which is available at http://onlinelibrary.wiley.com/doi/10. 1111/acem.13368/full). We also searched the following online databases to avoid missing relevant unpublished articles and abstracts: ClinicalTrials.gov, open grey, OpenDOAR, BASE, WorldWideScience.org, Mednar, and HSO. We also completed a hand search of references of included studies. We included studies that recruited all adult ED patients with a psychiatric chief complaint and performed a protocolized set of laboratory tests for medical clearance. Studies were only included if they provided enough data on the laboratory test results and described how abnormal or normal test results impacted patient disposition (whether results were clinically significant). We limited studies to the English language.
Quality Assessment
We used the Newcastle-Ottawa quality assessment scale 26 for assessing the quality of nonrandomized studies in meta-analyses. The Newcastle-Ottawa scale rates the quality of categories pertaining to observational and cohort studies. Categories include selection, comparability, and outcome. Two reviewers independently assessed each study using the checklist. A meeting was held with four of the authors (AC, RB, ES, and MPJ) to discuss the results of the quality assessment. Any disagreements were resolved by consensus with the fifth author (RS). All authors had 100% agreement with the final results reported in Table 2 . Inter-class correlation coefficient (ICC) was calculated to measure inter-rater reliability between reviewers using SPSS (IBM SPSS, Version 20, IBM Corp.).
Data Abstraction
Four authors (AC, RB, ES, and MPJ) independently selected articles from the combined PubMed/Embase/ Scopus search for full-text review. Each reviewer independently selected potentially eligible studies. Any disagreement about whether to include an article or not was resolved by consensus after a meeting with the fifth author (RS) before a final list of included studies was made. Reference lists of included studies were reviewed to identify additional studies for inclusion. When all necessary data were not provided in the text of the included studies, reviewers contacted the authors and requested the raw data.
Data Analysis
Data were reported as means with 95% confidence intervals (CIs). Prevalence data were reported as the percentage of abnormal tests with 95% CIs. We calculated the prevalence of total and clinically significant abnormal tests weighted by sample size using Microsoft Excel 2013 and attempted to calculate the pooled operating characteristics of each laboratory test in prediction of change in disposition (clinical significance).
RESULTS
The PubMed, Embase, and Scopus searches identified 2,847 citations. We excluded any article that did not clearly specify that laboratory screening tests were ordered as part of a protocol and not at discretion of the treating physician (nonprotocolized studies) 12, 16, [27] [28] [29] [30] [31] or articles that only ran protocolized laboratory screening in a subgroup of patients, e.g., in those who did not need laboratory tests according to treating physician. 16 We also excluded one article that performed protocolized laboratory screening only on admission to the psychiatric ward as opposed to in the ED. 32 The rationale for excluding this article was that patients on admission to the psychiatric ward were already medically cleared in the ED. Articles were also removed if they only included patients from a psychiatric ED or inpatient ward. 17, 27, [33] [34] [35] [36] [37] Four articles were removed for only including a preselected set of psychiatric chief complaints. 9, [38] [39] [40] One article only included aggressive patients requiring sedation, 38 and another only included patients with new-onset psychiatric symptoms. 9 Two articles were removed for only including patients with suspected suicidal ingestion or ingestion with drugs of misuse. 40, 41 Three articles were included in our review (see Figure 1 for the study selection process).
Description of Included Studies
Three studies were included in this review 5, 15, 41 (total patients n = 629). Table 1 provides a description of included studies. All three studies were retrospective in design. 5, 15, 41 All studies were completed in the general ED setting. Sample size varied from 80 15 to 345. In two studies, 5, 41 male participants were more prevalent than females (64% male in Olshaker et al. 5 and 70% male in Schauer and Goolsby 41 ). One study did not report data on the sex of their participants. 15 The inclusion criteria were not completely uniform across the studies. In the three studies 5,15,41 a set of protocolized laboratory tests were requested for all patients with a psychiatric chief complaint requiring medical clearance. Korn et al. 15 only included isolated psychiatric chief complaints with a preexisting psychiatric history but without a medical complaint. Schauer and Goolsby 41 and Olshaker et al. 5 included all patients with psychiatric chief complaints undergoing medical clearance with and without a medical complaint/history. Laboratory tests requested varied between studies. The three studies 5, 15, 41 had complete blood count (CBC), a metabolic panel, and urine drug screen (UDS) as part of their protocol. Two studies 15, 41 ordered pregnancy tests. One study 41 investigated acetaminophen (APAP), ethanol, and aspirin (ASA) levels. One study 41 also reported urinalysis. The only radiology study reported was chest x-ray (CXR), which was part of medical clearance in Korn et al. 15 Authors were contacted with requests for the patient-level data but we did not receive any responses. Table 2 indicates the results of each individual study quality assessment according to the Newcastle-Ottawa scale. The included studies were not cohort studies in design and therefore not every category and/or item included in the scale is applicable, but we have summarized the results of the applicable categories of Selection and Outcome. We could not assess items relating to comparability or nonexposure cohorts because our included studies were not designed to compare exposure to nonexposure cohorts. The studies were designed to include all psychiatric patients requiring mandated laboratory screening tests. Two
Quality Assessment of Included Studies
reviewers rated the study quality according to the checklist and their responses were analyzed to quantify inter-rater reliability. ICC was 1.0.
Within the category of "selection," selection item one involves "representativeness of the exposed cohort." All three studies 5, 15, 41 included all patients presenting with a psychiatric chief complaint to their respective EDs within their selected time frames (2 months, 5 5 months, 15 and 10 months 41 ). Because every presenting psychiatric patient was included, all studies were determined to truly represent the psychiatric patient population requiring medical clearance. Schauer and Goolsby 41 also utilized daily logs and transfer logs to ensure that no patients were missed. Additionally, all three studies 5, 15, 41 utilized secure records for data collection-electronic medical records.
Regarding the "outcome" category, outcomes from each study 5, 15, 41 were assessed via record linkage by Articles identified through bibliography search (n=1) Figure 1 . Study selection process. *Nongeneral ED: Study setting took place outside of the general ED, i.e., psychiatric ED or inpatient ward. Nonprotocolized: Study methodology did not utilize a predetermined, mandatory medical clearance protocol; i.e., tests were ordered by clinical judgment of the treating physician.
means of the patient's medical record. Information pertaining to test results, clinical significance, and disposition were obtained via the secure record. Additionally, all patients were followed throughout the duration of their ED visit until they were transferred to a medical or psychiatric unit. Therefore, the follow-up for all three studies were determined to be long enough for outcomes to occur. All patients were also accounted for throughout the duration of their ED visit, no patients were lost to follow-up. Complete data were reported for 100% of all patients for Korn et al., 15 and Olshaker et al. 5 and Schaeur et al. 41 reported complete data for 99.02% of all patients (two of 204 records were incomplete). APAP = acetaminophen; ASA = aspirin; BUN = blood urea nitrogen; CBC = complete blood count; CMP = comprehensive metabolic panel; CXR = chest x-ray; EtOH = ethanol; HCG = human chorionic gonadotropin; UDS = urine drug screen. 2) Selection of the nonexposed cohort-A = drawn from the same community as the exposed cohort; B = drawn from a different source; C = no description of the derivation of the nonexposed cohort.
3) Ascertainment of exposure-A = secure record (e.g., surgical records); B = structured interview; C = written self-report; D = no description. 4) Demonstration that outcome of interest was not present at start of study-A = yes; B = no. Comparability: 1) Comparability of cohorts on the basis of the design or analysis: A = study controls for (not applicable); B = study controls for any additional factor (these criteria could be modified to indicate specific control for a second important factor). Outcome: 1) Assessment of outcome-A = independent blind assessment; B = record linkage; C = self-report; D = no description.
2) Was follow-up long enough for outcomes to occur-A = yes (select an adequate follow-up period for outcome of interest); B = no.
3) Adequacy of follow-up of cohorts-A-complete follow up, all subjects accounted for; B-small number of subjects lost to follow-up unlikely to introduce bias; C-no description of subjects lost; D-no statement on loss to follow-up. -7) , APAP, ASA, and CXR. Abnormal tests ranged from 0% to 28% in pooled prevalence, whereas clinically significant results ranged from 0% to 0.4% in pooled prevalence. The highest prevalence of clinical significance was found in the SMA-7 by a single study, 4 which revealed 2.6% significance, but the study failed to identify which electrolyte was abnormal. Overall, results suggest that although certain tests indicated abnormal results (CBC 7.9%; UDS 28%; ethanol 22%; CMP 24%; urinalysis 14%), few results yielded clinical significance (CBC 0.4%; UDS 0.0%; ethanol 0.0%; CMP 0.0%; urinalysis 0.0%).
DISCUSSION
We were unable to identify laboratory screening protocols or individual tests that would have clinical utility for the medical clearance of all psychiatric ED patients. Our included studies 5, 15, 41 suggest that laboratory screening is very low yield for ED psychiatric patients. Only 0.0% to 0.4% of abnormal test results changed patient disposition and were therefore deemed as clinically significant.
Our systematic review indicates that while abnormal test results can be prevalent (0%-41%), these results are unlikely to alter disposition (0.0%-0.4% pooled prevalence of clinically significant results). We found a lower prevalence (0.0%-0.4%) of clinically significant laboratory screening results compared to a systematic review conducted by Gregory et al. 11 (0.0%-6.1%). We conjecture that the reason for the higher rates of Gregory et al. 11 are secondary to inclusion of nonprotocolized studies of laboratory screening tests for medical clearance. A nonprotocolized set of medical clearance laboratory tests may increase the prevalence of abnormal and clinically significant test results. Gregory et al. 11 also included studies in varying settings such as general and psychiatric EDs and inpatient wards. Commingling of psychiatric patients from disparate centers also allows for the risk of selection bias. Patients from psychiatric EDs and inpatients would have been prescreened, and the prevalence of abnormal tests on medical screening would likely have been increased.
This systematic review attempted to eliminate selection bias by excluding studies where laboratory tests were ordered according to subjective clinical judgment and only including articles that utilized a prespecified protocol for medical clearance. Study quality was rated according to the Newcastle-Ottawa scale, which revealed several areas of potential bias (see Table 2 for the Newcastle-Ottawa quality assessment results). All three of the studies 5, 15, 41 present with a high risk of selection bias because they use convenience sampling without a predetermined sample size and stopping rule. The authors did not disclose the percentage of psychiatric patients who presented to the ED but were not enrolled. Additionally, they did not compare potential and enrolled patients.
The methodology of the three studies 5, 15, 41 are at high risk of abstraction bias: Two of the three studies 15, 41 conducted chart reviews by one authordata collection was therefore unblinded and reviewer agreement could not be quantified. The third study 5 utilized four unblinded reviewers without conducting an analysis of interrater reliability between reviewers.
None of the studies 5, 15, 41 followed-up with medically cleared patients; therefore, it is unclear whether there were any bounce-backs to the ED, which would indicate that something was missed. It is also unclear in the three studies how clinical significance was assessed or who came to this determination (ED attending, resident, etc.).
Although our systematic review cannot determine an appropriate laboratory screening protocol for medical clearance of psychiatric patients in the ED, our results support the suggested guidelines for appropriate medical clearance. The American College of Emergency Physicians recommends only prescribing testing if indicated by history and physical examination. 2 Additionally, guidelines proposed in the literature have suggested that psychiatric patients presenting to the general ED with a preexisting psychiatric history and no comorbid medical illnesses may be medically cleared unless clinically indicated by vital signs, history, and physical examination. 13, 14 The decision to order ancillary testing, however, depends on subjective clinical judgment. If the treating physician determines that it is in the patient's best interest to have ancillary tests ordered this takes precedence over all suggested medical clearance guidelines.
A precise algorithm for appropriate mandatory laboratory screening has not been established; however, the literature on medical clearance agrees that ancillary testing should be required for high-risk psychiatric populations 15 such as new-onset psychiatric symptoms, 9 presence of comorbid and preexisting medical illnesses, suicidal patients, and patients older than 65 years of age. 6, 42 This suggests that laboratory screening for medical clearance would be appropriate for patients presenting without a past psychiatric history and/or an abnormal physical examination. For example, two studies 39, 43 investigated suicidal ingestion as a subgroup requiring more targeted laboratory screening for medical clearance that were excluded from our systematic review for lack of a protocol and for only including this subgroup found that a small percentage (0.5 and 2.2%, respectively) of potentially hepatotoxic intoxications of APAP for patients who had a suspected suicidal ingestion without disclosing exposure to this drug. Without routine APAP screening, these potentially life-threatening overdoses may have been missed. Additionally, blood alcohol level and UDS has been recommended for patients presenting with a history of substance abuse or signs of intoxication.
We were unable to assess the level of clinically significant laboratory results in high-risk patients due to lack of data. Our included studies 5, 15, 41 did not stratify patients by these high-risk subgroups. One study 15 did divide patients into two groups by the presence or absence of a comorbid medical complaint, but because this was the sole study in our review that separated these groups we are unable to compare results.
LIMITATIONS
We did not have access to patient-level data; therefore, it was impossible to evaluate the effect of factors such as psychiatric diagnosis, medical illness diagnosis, ED length of stay, cost of ED procedures, ethnicity, or socioeconomic status. There was also a paucity of literature on this topic, and we therefore could not determine the clinical utility of protocolized laboratory screening tests for medical clearance of psychiatric patients in the ED. All studies on psychiatric medical clearance included in this review were done in an ED academic setting and therefore results might not be generalizable to other settings. Moreover, the inclusion and exclusion criteria varied significantly among the included studies.
Our three included studies 5, 15, 41 defined "clinical significance" solely as a laboratory test result that altered patient disposition, which does not account for other significant changes in treatment. In addition to changing disposition, abnormal laboratory test results may also alter patient treatment or prolong their length of stay in the ED; therefore, the definition of "clinical significance" should be broadened. Finally, only Englishlanguage studies were included; however, language restriction in systematic reviews and meta-analyses in medicine has not been shown to result in bias. 45 
CONCLUSION
The clinically significant laboratory test results ordered indiscriminately by protocol in psychiatric patients were low, which suggests that according to current studies routine laboratory measures are unlikely to alter subsequent medical decisions. Although the amount and overall quality of evidence is low, there is insufficient evidence to support routine laboratory screening in psychiatric patients in the ED. Due to the paucity of available research on this subject, we could not determine the clinical utility of protocolized laboratory screening tests for medical clearance of psychiatric patients in the ED.
Areas of Future Research
The value of mandating laboratory screening for ED psychiatric patient care is a high-yield research area in an era of Choosing Wisely and shared decision making, which stresses the importance of a patient-centered approach to health care. 22, 23 The question of whether laboratory screening is beneficial for patient care is particularly critical when considering the financial strains of unnecessary laboratory tests 14, 18 and the patient safety risks associated with prolonged ED length of stay. 6 To help guide ED physicians patientcentered approach to medical clearance, future studies should investigate multiple laboratory screening protocols in diverse ED settings and determine the individual tests that demonstrated clinical significance. Emergency physicians could refer to this protocol to aid in prescribing appropriate laboratory testing for psychiatric patients.
Future prospective observational research on this topic that is designed in accordance to a validated tool such as STROBE 44 would substantially decrease the risk of bias. Additionally, explicit definitions by emergency medicine, psychiatrist, patients, and other stakeholders for clinical significance and prospective followup with patients would also significantly reduce the risk of bias. Long-term follow-up could identify bounce-backs to the ED and any medically cleared laboratory tests that eventually became clinically significant after discharge. Future emergency medicine, psychiatry, hospitalist, and nursing researchers should broaden the definition of clinical significance to also include laboratory test results that led to a change in treatment and/or prolonging ED length of stay. Future researchers should also begin to differentiate clinically significant versus nonsignificant laboratory test results in this population based on history and physical examination. A preexisting psychiatric history and normal physical examination have been suggested to be adequate determinants for medical clearance. 2 This information could also be used to better interpret the clinical significance of laboratory test results.
Clinical significance should be determined in real time via the treating physician to establish validity of the construct. Determining clinical significance retrospectively through chart review alone can lead to a judgment error on the part of the investigators.
Determining clinical significance in real time would delineate the extent to which the laboratory test result informed physician decision making. Retrospective chart review fails to account for the multifarious factors involved in decision making. For example, the investigators may see a low glucose in a patient's chart who was admitted to medicine instead of psychiatry and draw the conclusion that hypoglycemia was the rationale behind failure to medically clear. But how can we truly know that other factors did not affect the physician's decision? Individual patient characteristics such as age or specific comorbidity could affect the decision to clear or admit the patient. The only way to determine the relevance of the laboratory test result in medically clearing a patient is to obtain this information from the physician in real time.
Beyond validity, in an effort to move toward a patient-centered approach to medical clearance of ED psychiatric patients, the assessment of clinical significance should also include the collection and measurement of patient and clinician acceptability and intraprovider acceptability. This information would be salient in understanding decision making and agreement on treatment among providers and patients.
